>
"A Very Good, Early Step" - Trump Announces Meeting Between Putin and Zelensky...
Comer Discloses Some Details From Bill Barr's Deposition Related to Epstein Investigation (VIDEO
ADU Fever: Inside The Backyard Housing Boom In California
How Much Energy Does ChatGPT's Newest Model Consume?
Chinese Scientists Produce 'Impossible' Steel to Line Nuclear Fusion Reactors in Major Break
1,000 miles: EV range world record demolished ... by a pickup truck
Fermented Stevia Extract Kills Pancreatic Cancer Cells In Lab Tests
3D printing set to slash nuclear plant build times & costs
You can design the wheels for NASA's next moon vehicle with the 'Rock and Roll Challenge
'Robot skin' beats human reflexes, transforms grip with fabric-powered touch
World's first nuclear fusion plant being built in US to power Microsoft data centers
The mitochondria are more than just the "powerhouse of the cell" – they initiate immune...
Historic Aviation Engine Advance to Unlock Hypersonic Mach 10 Planes
OpenAI CEO Sam Altman Pitches Eyeball-Scanning World ID to Bankers
The National Institutes of Health announces funding of more than 200 new awards, totaling over $220 million, through the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, an exciting trans-agency effort to arm researchers with revolutionary tools to fundamentally understand the neural circuits that underlie the healthy and diseased brain. Supported by the Congress through both the regular appropriations process and the 21st Century Cures Act, this brings the total 2018 support for the program to more than $400 million, which is 50 percent more than the amount spent last year. Many of the new awards explore the human brain directly. Furthermore, the NIH is trying to leverage some BRAIN Initiative advances to help tackle the pain and opioid crisis.
"Brain diseases are some of the greatest mysteries in modern medicine. These projects will provide new tools and knowledge needed to discover answers for some of the most difficult neurological and neuropsychiatric disorders," said NIH Director Francis S. Collins, M.D., Ph.D.